Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 5
2017 2
2018 1
2019 2
2020 1
2021 2
2022 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Myelodysplastic Syndromes and Metabolism.
Balaian E, Wobus M, Bornhäuser M, Chavakis T, Sockel K. Balaian E, et al. Int J Mol Sci. 2021 Oct 19;22(20):11250. doi: 10.3390/ijms222011250. Int J Mol Sci. 2021. PMID: 34681910 Free PMC article. Review.
VEXAS syndrome: complete molecular remission after hypomethylating therapy.
Sockel K, Götze K, Ganster C, Bill M, Georgi JA, Balaian E, Aringer M, Trautmann-Grill K, Uhlig M, Bornhäuser M, Haase D, Thiede C. Sockel K, et al. Among authors: balaian e. Ann Hematol. 2024 Mar;103(3):993-997. doi: 10.1007/s00277-023-05611-w. Epub 2024 Jan 12. Ann Hematol. 2024. PMID: 38214707 Free PMC article.
Half-dose glucarpidase as efficient rescue for toxic methotrexate levels in patients with acute kidney injury.
Heuschkel S, Kretschmann T, Teipel R, von Bonin S, Richter S, Quick S, Alakel N, Röllig C, Balaian E, Kroschinsky F, Knoth H, Bornhäuser M, von Bonin M. Heuschkel S, et al. Among authors: balaian e. Cancer Chemother Pharmacol. 2022 Jan;89(1):41-48. doi: 10.1007/s00280-021-04361-8. Epub 2021 Oct 20. Cancer Chemother Pharmacol. 2022. PMID: 34669022 Free PMC article.
Machine learning assisted real-time deformability cytometry of CD34+ cells allows to identify patients with myelodysplastic syndromes.
Herbig M, Jacobi A, Wobus M, Weidner H, Mies A, Kräter M, Otto O, Thiede C, Weickert MT, Götze KS, Rauner M, Hofbauer LC, Bornhäuser M, Guck J, Ader M, Platzbecker U, Balaian E. Herbig M, et al. Among authors: balaian e. Sci Rep. 2022 Jan 18;12(1):870. doi: 10.1038/s41598-022-04939-z. Sci Rep. 2022. PMID: 35042906 Free PMC article.
Disease-modifying activity of ruxolitinib in a patient with JAK2-negative CMML-2.
Francke S, Mies A, Meggendorfer M, Oelschlaegel U, Balaian E, Gloaguen S, Haferlach T, Ehninger G, Bornhäuser M, Platzbecker U. Francke S, et al. Among authors: balaian e. Leuk Lymphoma. 2017 May;58(5):1271-1272. doi: 10.1080/10428194.2016.1225209. Epub 2016 Sep 23. Leuk Lymphoma. 2017. PMID: 27659716 No abstract available.
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure.
Mossner M, Jann JC, Wittig J, Nolte F, Fey S, Nowak V, Obländer J, Pressler J, Palme I, Xanthopoulos C, Boch T, Metzgeroth G, Röhl H, Witt SH, Dukal H, Klein C, Schmitt S, Gelß P, Platzbecker U, Balaian E, Fabarius A, Blum H, Schulze TJ, Meggendorfer M, Haferlach C, Trumpp A, Hofmann WK, Medyouf H, Nowak D. Mossner M, et al. Among authors: balaian e. Blood. 2016 Sep 1;128(9):1246-59. doi: 10.1182/blood-2015-11-679167. Epub 2016 Jun 6. Blood. 2016. PMID: 27268087 Free article.
13 results